Steve

Steve

Writing about Open Class Action Lawsuits and Dementia Science and Tips since 2019!

Are Alzheimer’s Drugs Facing Dangerous Approval Lawsuits

Alzheimer’s drugs, particularly the newer amyloid-targeting therapies like lecanemab (marketed as Leqembi), are currently navigating a complex and somewhat precarious landscape involving regulatory approvals and legal challenges. While these drugs represent significant scientific progress in treating early-stage Alzheimer’s disease, they…

Could Pharma Companies Be Sued Over ADHD Drug Risks

Pharmaceutical companies can potentially be sued over the risks associated with ADHD drugs, but whether such lawsuits succeed depends on several legal and scientific factors. The core legal basis for suing pharma companies typically revolves around product liability claims, especially…

Will EPA Be Sued for Failing to Regulate Toxins

The Environmental Protection Agency (EPA) is currently facing significant legal challenges over its handling of toxic substances, particularly a group of chemicals known as PFAS (per- and polyfluoroalkyl substances), often called “forever chemicals” due to their persistence in the environment.…